These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16832080)

  • 1. Elevated cortical zinc in Alzheimer disease.
    Religa D; Strozyk D; Cherny RA; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush AI
    Neurology; 2006 Jul; 67(1):69-75. PubMed ID: 16832080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
    Bennett DA; Schneider JA; Wilson RS; Bienias JL; Arnold SE
    Arch Neurol; 2004 Mar; 61(3):378-84. PubMed ID: 15023815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia.
    Zekry D; Duyckaerts C; Belmin J; Geoffre C; Moulias R; Hauw JJ
    Acta Neuropathol; 2003 Oct; 106(4):367-73. PubMed ID: 12898153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.
    Forman MS; Mufson EJ; Leurgans S; Pratico D; Joyce S; Leight S; Lee VM; Trojanowski JQ
    Neurology; 2007 Mar; 68(10):757-63. PubMed ID: 17339583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain.
    Zhang LH; Wang X; Stoltenberg M; Danscher G; Huang L; Wang ZY
    Brain Res Bull; 2008 Sep; 77(1):55-60. PubMed ID: 18639746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
    Jeynes B; Provias J
    Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Abeta levels do not reflect brain Abeta levels.
    Freeman SH; Raju S; Hyman BT; Frosch MP; Irizarry MC
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):264-71. PubMed ID: 17413317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
    Hellström-Lindahl E; Ravid R; Nordberg A
    Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
    Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
    Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease.
    Mastaglia FL; Masters CL; Beyreuther K; Kakulas BA
    Prog Clin Biol Res; 1989; 317():475-84. PubMed ID: 2690109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
    Zipser BD; Johanson CE; Gonzalez L; Berzin TM; Tavares R; Hulette CM; Vitek MP; Hovanesian V; Stopa EG
    Neurobiol Aging; 2007 Jul; 28(7):977-86. PubMed ID: 16782234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.
    Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
    Neurology; 2007 Mar; 68(12):927-31. PubMed ID: 17372128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, genes and zinc in Alzheimer's disease.
    Vasto S; Candore G; Listì F; Balistreri CR; Colonna-Romano G; Malavolta M; Lio D; Nuzzo D; Mocchegiani E; Di Bona D; Caruso C
    Brain Res Rev; 2008 Jun; 58(1):96-105. PubMed ID: 18190968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta aggregation.
    Finder VH; Glockshuber R
    Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.